Screener
Dianthus Therapeutics DNTH Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Dianthus Therapeutics’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001690585-26-000022
FAQ
- What is Dianthus Therapeutics's shares (diluted)?
- Dianthus Therapeutics (DNTH) reported shares (diluted) of 48M in Q1 2026.
- How has Dianthus Therapeutics's shares (diluted) changed year-over-year?
- Dianthus Therapeutics's shares (diluted) increased by 34.2% year-over-year, from 35.8M to 48M.
- What is the long-term trend for Dianthus Therapeutics's shares (diluted)?
- Over 3 years (2021 to 2024), Dianthus Therapeutics's shares (diluted) has grown at a -16.1% compound annual growth rate (CAGR), from 215.8M to 127.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Dianthus Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude